Nothing Special   »   [go: up one dir, main page]

Gautam et al., 2013 - Google Patents

Comparision of Screening Methods for Detection of Extended Spectrum β-Lactamases

Gautam et al., 2013

View PDF
Document ID
7996809623258760017
Author
Gautam A
Chaturvedi A
Shukla S
Publication year
Publication venue
Biosciences

External Links

Snippet

01-532 (VK MISHRA).pmd Page 1 www.IndianJournals.com Members Copy, Not for Commercial Sale Downloaded From IP - 66.249.68.64 on dated 18-Apr-2024 Trends in Biosciences 6 (5): 651-654, 2013 Comparision of Screening Methods for Detection of Extended Spectrum β …
Continue reading at www.researchgate.net (PDF) (other versions)

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay
    • G01N33/569—Immunoassay; Biospecific binding assay for micro-organisms, e.g. protozoa, bacteria, viruses
    • G01N33/56911—Bacteria
    • G01N33/56938—Staphylococcus
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay
    • G01N33/569—Immunoassay; Biospecific binding assay for micro-organisms, e.g. protozoa, bacteria, viruses
    • G01N33/56911—Bacteria
    • G01N33/56916—Enterobacteria, e.g. shigella, salmonella, klebsiella, serratia
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/90—Enzymes; Proenzymes
    • G01N2333/914—Hydrolases (3)
    • G01N2333/978—Hydrolases (3) acting on carbon to nitrogen bonds other than peptide bonds (3.5)
    • G01N2333/986—Hydrolases (3) acting on carbon to nitrogen bonds other than peptide bonds (3.5) acting on amide bonds in cyclic amides (3.5.2), e.g. beta-lactamase (penicillinase, 3.5.2.6), creatinine amidohydrolase (creatininase, EC 3.5.2.10), N-methylhydantoinase (3.5.2.6)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES OR MICRO-ORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/02—Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions involving viable micro-organisms
    • C12Q1/04—Determining presence or kind of micro-organism; Use of selective media for testing antibiotics or bacteriocides; Compositions containing a chemical indicator therefor
    • C12Q1/06—Quantitative determination
    • C12Q1/08—Quantitative determination using multifield media
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/195—Assays involving biological materials from specific organisms or of a specific nature from bacteria
    • G01N2333/24—Assays involving biological materials from specific organisms or of a specific nature from bacteria from Enterobacteriaceae (F), e.g. Citrobacter, Serratia, Proteus, Providencia, Morganella, Yersinia
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/195—Assays involving biological materials from specific organisms or of a specific nature from bacteria
    • G01N2333/315—Assays involving biological materials from specific organisms or of a specific nature from bacteria from Streptococcus (G), e.g. Enterococci
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES OR MICRO-ORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/02—Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions involving viable micro-organisms
    • C12Q1/18—Testing for antimicrobial activity of a material

Similar Documents

Publication Publication Date Title
Younas et al. AmpC beta-lactamases in Klebsiella pneumoniae: An emerging threat to the paediatric patients'
JP7376625B2 (en) Compositions, methods, systems and/or kits for detecting antimicrobial resistance in bacteria
Iliyasu et al. Phenotypic detection of multidrug resistant extended-spectrum beta-lactamase (ESBL) producing Escherichia coli from clinical samples
Nirmala et al. Aerobic bacterial isolates and their antibiotic susceptibility pattern from pus samples in a tertiary care government hospital in Tamilnadu, India
Mowla et al. Emergence of multidrug resistant extended-spectrum β-lactamase producing Eshcherichia coli associated with urinary tract infections in Bangladesh
JP7479433B2 (en) Method for detecting class A carbapenemase-producing bacteria and multi-well plate for detection
Gautam et al. Comparision of Screening Methods for Detection of Extended Spectrum β-Lactamases
Akpu et al. Phenotypic Detection of AmpC beta-lactamase Producing Escherichia coli among Patients in Hospital Wards
Kałużna et al. Comparison of detection methods for extended-spectrum beta-lactamases in Escherichia coli strains
Hussein Phenotypic detection of extended –spectrum betalactamase production in Proteus. mirabilis isolation from Patients with Significant Bacteriuria in Najaf provina
Faari et al. Prevalence of extended spectrum beta-lactamase-producing Klebsiella species at the university of ilorin teaching hospital
Tewari et al. Prevalence of extended-spectrum βlactamase in Pseudomonas aeruginosa in tertiary care centre
Shiraz et al. Evaluation of Carbapenemase Resistance in Pseudomonas Aeruginosa and Enterobacteriaceae Family Isolated from Clinical Specimens by Using Phenotypic Methods
Adeyemi et al. ESβL and MβL Production in Gram-Negative Bacteria Isolated From HIV Seropositive Individuals
Nwokafor et al. The Prevalence of Extended Spectrum Beta-Lactamase Producing Uropathogenic Escherichia coli from Mouau Female Hostel Students
Habib et al. Frequency and susceptibility pattern of extended spectrum beta lactamase producing aerobic gram negative bacteria in postoperative infections
Eldeeb et al. In vitro activity of tigecycline against local clinical isolates of some Enterobacteriaceae
Pattanayak et al. Phenotypic Detection of Multidrug-Resistance Pseudomonas aeruginosa Isolated from Various Clinical Samples
Jafar et al. Prevalence and antimicrobial susceptibility patterns of extended spectrum β-lactamase producers and non-producers Pseudomonas aeruginosa in Peshawar
Kumar Sharma et al. Antimicrobial Activity of Ceftazidime-Avibactam (CAZ-AVI) among the Carbapenemase-Producing Gram-negative Rods Isolated from Clinical Samples
Ramalivhana et al. Antimicrobial susceptibility testing of Aeromonas hydrophila isolated from Limpopo Province, South Africa using VITEK 2 system, Micro Scan Walk Away, disk diffusion and E-test method
Bora et al. Incidence & Estimation of Beta–Lactamase Enzymes (ESBL Ampc, Carbapenemase Enzymes) singly and their coexistence in clinical isolates of Gram Negative bacteria by Vitek–2 Compact System
Sabirovna et al. ANTIBIOTIC RESISTANCE OF MICROORGANISMS IN PATIENTS WITH INFLAMMATORY PROCESSES OF THE URINARY SYSTEM
Bhandari et al. Increased biofilm-associated Carbapenem-resistant Acinetobacter-calcoaceticus-baumannii complex infections among the hospitalized patients in Kathmandu Model Hospital, Nepal
Iliya et al. Antibiotic resistance of Klebsiella pneumoniae isolated from rectal swabs of neonates from some hospitals within Kaduna metropolis